Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Grade Glioma: Glioblastoma (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04630379
What this trial is testing

Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers

Who this might be right for
GlioblastomaMalignant GliomaWHO Grade III Glioma
Mayo Clinic 16
Not applicableUnknownNCT02047058
What this trial is testing

Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics

Who this might be right for
GlioblastomaMalignant Glioma
Nanfang Hospital, Southern Medical University 240
Not applicableWithdrawnNCT00645385
What this trial is testing

Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT02315534
What this trial is testing

BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma

Who this might be right for
Glioblastoma
Sumitomo Pharma America, Inc. 34
Early research (Phase 1)Study completedNCT01316809
What this trial is testing

AZD8055 for Adults With Recurrent Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+2 more
National Cancer Institute (NCI) 22
Not applicableStudy completedNCT01653834
What this trial is testing

Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas

Who this might be right for
Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10
Very early researchNot Yet RecruitingNCT07778602
What this trial is testing

Safety and Feasibility of First-line Avutometinib and Defactinib in Patients With Newly Diagnosed High-grade Gliomas

Who this might be right for
MGMT-unmethylated Glioblastoma (GBM)IDH Wildtype Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Not applicableStudy completedNCT03877861
What this trial is testing

Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms

Who this might be right for
GliomaGlioblastoma
Allina Health System 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT06521567
What this trial is testing

Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

Who this might be right for
MelanomaHodgkin LymphomaHigh and Low Grade Glioma+9 more
GlaxoSmithKline 83
Early research (Phase 1)Ended earlyNCT04327011
What this trial is testing

A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511

Who this might be right for
Glioblastoma MultiformeAstrocytomaGliomas, Malignant
Tocagen Inc. 65
Testing effectiveness (Phase 2)Study completedNCT02343406
What this trial is testing

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

Who this might be right for
Glioblastoma
AbbVie 266
Testing effectiveness (Phase 2)Study completedNCT06562621
What this trial is testing

Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma

Who this might be right for
Glioblastoma MultiformeGliomas, Malignant
Beijing Neurosurgical Institute 38
Early research (Phase 1)Study completedNCT05362409
What this trial is testing

Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma

Who this might be right for
High Grade Glioma
Alpheus Medical, Inc. 22
Early research (Phase 1)Study completedNCT02644291
What this trial is testing

Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors

Who this might be right for
MedulloblastomaAstrocytoma, Grade IIIGlioblastoma+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 16
Testing effectiveness (Phase 2)Study completedNCT00268359
What this trial is testing

Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 68
Testing effectiveness (Phase 2)Ended earlyNCT00003535
What this trial is testing

Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma

Who this might be right for
High Grade Glioma
Burzynski Research Institute 9
Early research (Phase 1)Ended earlyNCT06193174
What this trial is testing

Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)

Who this might be right for
Recurrent Malignant GliomaGlioblastoma Multiforme of BrainGliosarcoma of Brain+1 more
University of Alabama at Birmingham 1
Testing effectiveness (Phase 2)Study completedNCT02465268
What this trial is testing

Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma MultiformeGlioblastomaMalignant Glioma+2 more
University of Florida 175
Not applicableStudy completedNCT04726397
What this trial is testing

UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial

Who this might be right for
Glioblastoma Multiforme
Sunnybrook Health Sciences Centre 108
Testing effectiveness (Phase 2)Study completedNCT00004868
What this trial is testing

SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Next Page